{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:29:26Z","timestamp":1776601766354,"version":"3.51.2"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.drugalcdep.2020.108302","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:24:12Z","timestamp":1600428252000},"page":"108302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["COVID-19 survey among people who use drugs in three cities in Norway"],"prefix":"10.1016","volume":"217","author":[{"given":"Gabrielle K.","family":"Welle-Strand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Skurtveit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Sundal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linn","family":"Gjersing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.108302_bib0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12913-019-4282-z","article-title":"Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study","volume":"19","author":"Bech","year":"2019","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2020.108302_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta\u2010analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108302_bib0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.dsx.2020.06.008","article-title":"COVID-19 and addiction","volume":"14","author":"Dubey","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.drugalcdep.2020.108302_bib0020","series-title":"EU Drug Markets: Impact of COVID-19","author":"EMCDDA","year":"2020"},{"key":"10.1016\/j.drugalcdep.2020.108302_bib0025","first-page":"129","article-title":"Review paper: COVID-19 and substance use disorders: recommendations to healthcare response. An International Society of Addiction Medicine (ISAM) practice and policy interest group position paper","volume":"11","author":"Farhoudian","year":"2020","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.drugalcdep.2020.108302_bib0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/add.14053","article-title":"Patterns of substance use and mortality risk in a cohort of\u2019 hard-to-reach\u2019 polysubstance users","volume":"113","author":"Gjersing","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108302_bib0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addbeh.2017.05.005","article-title":"The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland","volume":"73","author":"Latkin","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2020.108302_bib0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/add.14425","article-title":"Naloxone distribution and possession following a large-scale naloxone programme","volume":"114","author":"Madah-Amiri","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108302_bib0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2471\/BLT.12.108282","article-title":"Mortality among people who inject drugs: a systematic review and meta-analysis","volume":"91","author":"Mathers","year":"2013","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.drugalcdep.2020.108302_bib0050","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1360-0443.2011.03463.x","article-title":"Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial","volume":"106","author":"Reimer","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108302_bib0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/1874473711205040004","article-title":"Substance-related disorders and somatic symptoms: how should clinicians understand the associations?","volume":"5","author":"Yoshimasu","year":"2012","journal-title":"Curr. Drug Abuse Rev."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:08:25Z","timestamp":1759828105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620304671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":11,"alternative-id":["S0376871620304671"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108302","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 survey among people who use drugs in three cities in Norway","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108302"}}